Alcon to Acquire EYSUVIS Adding to Its Ophthalmic Eye Drop P

23.05.2022 - Alcon (SIX/NYSE: ALC), the global leader in eye care dedicated to helping people see brilliantly, today announced it has signed an agreement to acquire EYSUVIS (loteprednol etabonate suspension) 0.25% pharmaceutical eye drops from Kala ... Seite 1

Related Keywords

United States , Sergio Duplan , Kala Pharmaceuticals Inc , Drug Administration , North America , Kala Pharmaceuticals , Falcon ,